As a young, dynamic and creative molecular diagnostics company, we have specialized in simple and rapid solutions for the diagnosis of severe infectious diseases in hospitalized patients. We help to combat infections effectively and detect antibiotic resistance at an early stage.
Curetis Receives USPTO Notice of Allowance for Key Patent Covering Unyvero Technology
Curetis subsidiary Ares Genetics wins incubator stay in Silicon Valley
Deutsche Biotechnologietage 2018 - Berlin, Germany - April 18 to 19, 2018
28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Madrid, Spain - 21 to 24 April, 2018